Market Tracker

11/25 6:05pm ET

Incyte Corp (NASDAQ:INCY)

During the Trading Day
73.14 -2.40 / -3.18%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
73.14 0.00 / 0.00%
 
Volume: 1.7M

Today’s Trading

Previous close75.54
Today’s open75.79
Day’s range70.21 - 75.88
Volume7,072,665
Average volume (3 months)1,240,442
Market cap$12.8B
Dividend yield--
Data as of 3:59pm ET, 11/25/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+79.57%
Earnings growth (next 5 years)+79.00%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+1.51+1.72%
ENDPEndo International P...-0.28-0.39%
PCYCPharmacyclics Inc-1.64-1.17%
JAZZJazz Pharmaceuticals...-0.02-0.01%
Data as of 3:59pm ET, 11/25/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts